173 related articles for article (PubMed ID: 31416458)
1. New approaches for detecting cancer with circulating cell-free DNA.
Fiala C; Diamandis EP
BMC Med; 2019 Aug; 17(1):159. PubMed ID: 31416458
[No Abstract] [Full Text] [Related]
2. DNA methylation analysis explores the molecular basis of plasma cell-free DNA fragmentation.
An Y; Zhao X; Zhang Z; Xia Z; Yang M; Ma L; Zhao Y; Xu G; Du S; Wu X; Zhang S; Hong X; Jin X; Sun K
Nat Commun; 2023 Jan; 14(1):287. PubMed ID: 36653380
[TBL] [Abstract][Full Text] [Related]
3. Cell-free DNA in maternal blood and artificial intelligence: accurate prenatal detection of fetal congenital heart defects.
Bahado-Singh R; Friedman P; Talbot C; Aydas B; Southekal S; Mishra NK; Guda C; Yilmaz A; Radhakrishna U; Vishweswaraiah S
Am J Obstet Gynecol; 2023 Jan; 228(1):76.e1-76.e10. PubMed ID: 35948071
[TBL] [Abstract][Full Text] [Related]
4. Recent advances in blood-based and artificial intelligence-enhanced approaches for gastrointestinal cancer diagnosis.
Li LS; Guo XY; Sun K
World J Gastroenterol; 2021 Sep; 27(34):5666-5681. PubMed ID: 34629793
[TBL] [Abstract][Full Text] [Related]
5. The contribution of the 20th century discoveries on the circulating DNA as biomarkers for cancer screening.
Alves G; Chantre M; Delmonico L
An Acad Bras Cienc; 2020; 92(4):e20200919. PubMed ID: 33206793
[TBL] [Abstract][Full Text] [Related]
6. Somatic copy number alteration and fragmentation analysis in circulating tumor DNA for cancer screening and treatment monitoring in colorectal cancer patients.
Hallermayr A; Wohlfrom T; Steinke-Lange V; Benet-Pagès A; Scharf F; Heitzer E; Mansmann U; Haberl C; de Wit M; Vogelsang H; Rentsch M; Holinski-Feder E; Pickl JMA
J Hematol Oncol; 2022 Sep; 15(1):125. PubMed ID: 36056434
[TBL] [Abstract][Full Text] [Related]
7. Circulating cell-free DNA from plasma undergoes less fragmentation during bisulfite treatment than genomic DNA due to low molecular weight.
Werner B; Yuwono NL; Henry C; Gunther K; Rapkins RW; Ford CE; Warton K
PLoS One; 2019; 14(10):e0224338. PubMed ID: 31652288
[TBL] [Abstract][Full Text] [Related]
8. Inferring gene expression from cell-free DNA fragmentation profiles.
Esfahani MS; Hamilton EG; Mehrmohamadi M; Nabet BY; Alig SK; King DA; Steen CB; Macaulay CW; Schultz A; Nesselbush MC; Soo J; Schroers-Martin JG; Chen B; Binkley MS; Stehr H; Chabon JJ; Sworder BJ; Hui AB; Frank MJ; Moding EJ; Liu CL; Newman AM; Isbell JM; Rudin CM; Li BT; Kurtz DM; Diehn M; Alizadeh AA
Nat Biotechnol; 2022 Apr; 40(4):585-597. PubMed ID: 35361996
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic Biomarkers in Cell-Free DNA and Applications in Liquid Biopsy.
Gai W; Sun K
Genes (Basel); 2019 Jan; 10(1):. PubMed ID: 30634483
[TBL] [Abstract][Full Text] [Related]
10. Life and death of circulating cell-free DNA.
Kustanovich A; Schwartz R; Peretz T; Grinshpun A
Cancer Biol Ther; 2019; 20(8):1057-1067. PubMed ID: 30990132
[TBL] [Abstract][Full Text] [Related]
11. Liquid biopsy: state of reproductive medicine and beyond.
Schobers G; Koeck R; Pellaers D; Stevens SJC; Macville MVE; Paulussen ADC; Coonen E; van den Wijngaard A; de Die-Smulders C; de Wert G; Brunner HG; Zamani Esteki M
Hum Reprod; 2021 Oct; 36(11):2824-2839. PubMed ID: 34562078
[TBL] [Abstract][Full Text] [Related]
12. Integrity and Quantity of Total Cell-Free DNA in the Diagnosis of Thyroid Cancer: Correlation with Cytological Classification.
Salvianti F; Giuliani C; Petrone L; Mancini I; Vezzosi V; Pupilli C; Pinzani P
Int J Mol Sci; 2017 Jun; 18(7):. PubMed ID: 28672797
[TBL] [Abstract][Full Text] [Related]
13. Cell free circulating tumor nucleic acids, a revolution in personalized cancer medicine.
Kerachian MA; Poudineh A; Thiery JP
Crit Rev Oncol Hematol; 2019 Dec; 144():102827. PubMed ID: 31715326
[TBL] [Abstract][Full Text] [Related]
14. Circulating Cell Free Nuclear DNA, Mitochondrial DNA and Global DNA Methylation: Potential Noninvasive Biomarkers for Breast Cancer Diagnosis.
Pasha HA; Rezk NA; Riad MA
Cancer Invest; 2019; 37(9):432-439. PubMed ID: 31516038
[TBL] [Abstract][Full Text] [Related]
15. Circulating cell-free DNAs and miRNAs as promising non-invasive biomarkers for early detection of gastric cancer.
Liu X; Chu KM
Neoplasma; 2016; 63(1):1-9. PubMed ID: 26639229
[TBL] [Abstract][Full Text] [Related]
16. A new approach to epigenome-wide discovery of non-invasive methylation biomarkers for colorectal cancer screening in circulating cell-free DNA using pooled samples.
Gallardo-Gómez M; Moran S; Páez de la Cadena M; Martínez-Zorzano VS; Rodríguez-Berrocal FJ; Rodríguez-Girondo M; Esteller M; Cubiella J; Bujanda L; Castells A; Balaguer F; Jover R; De Chiara L
Clin Epigenetics; 2018; 10():53. PubMed ID: 29686738
[TBL] [Abstract][Full Text] [Related]
17. Size distribution of cell-free DNA in oncology.
Udomruk S; Orrapin S; Pruksakorn D; Chaiyawat P
Crit Rev Oncol Hematol; 2021 Oct; 166():103455. PubMed ID: 34464717
[TBL] [Abstract][Full Text] [Related]
18. Test for Methylated Cell-Free DNA Identifies Colorectal Cancer.
Cancer Discov; 2020 Mar; 10(3):337. PubMed ID: 31953244
[TBL] [Abstract][Full Text] [Related]
19. Tumor fractions deciphered from circulating cell-free DNA methylation for cancer early diagnosis.
Zhou X; Cheng Z; Dong M; Liu Q; Yang W; Liu M; Tian J; Cheng W
Nat Commun; 2022 Dec; 13(1):7694. PubMed ID: 36509772
[TBL] [Abstract][Full Text] [Related]
20. Orientation-aware plasma cell-free DNA fragmentation analysis in open chromatin regions informs tissue of origin.
Sun K; Jiang P; Cheng SH; Cheng THT; Wong J; Wong VWS; Ng SSM; Ma BBY; Leung TY; Chan SL; Mok TSK; Lai PBS; Chan HLY; Sun H; Chan KCA; Chiu RWK; Lo YMD
Genome Res; 2019 Mar; 29(3):418-427. PubMed ID: 30808726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
